AusCann's IPO

AusCann raised a round of funding on February 03, 2017. Investors include Public.

AusCann (ASX: AC8) is a producer of economical and clinically validated cannabis medicines that target palliative care symptoms, chemotherapy-induced nausea, treatment-resistant childhood epilepsy, an…

Articles about AusCann's IPO: